Eisai Appalled by the German Federal Joint Committee's Decision on Innovative Antiepileptic Drug Fycompa® (perampanel)
Frankfurt, Germany And Hatfield, England (ots/PRNewswire) - The German Federal Joint Committee (G-BA), the decision-making body of the self-governing medical system in Germany, today announced that it considers the additional benefit of Fycompa(R) (perampanel) unproven when compared to two other treatments as ...
plus